This is a preview of subscription content, log in via an institution to check access.
Notes
2014 values
Reference
Manchanda R, et al. Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women. Journal of the National Cancer Institute : 18 Jan 2018. Available from: URL: https://doi.org/10.1093/jnci/djx265
Rights and permissions
About this article
Cite this article
Population-based screening for gene mutations cost effective. PharmacoEcon Outcomes News 795, 23 (2018). https://doi.org/10.1007/s40274-018-4661-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-4661-4